تحميل...

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

BACKGROUND: Switch from first to second-line ART is recommended by WHO for patients with virologic failure. Delays in switching may contribute to accumulated drug resistance, advanced immunosuppression, increased morbidity and mortality. The 3rd 90′ of UNAIDS 90:90:90 targets 90% viral suppression f...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	BMC Infect Dis
المؤلفون الرئيسيون:	Ssempijja, Victor, Nakigozi, Gertrude, Chang, Larry, Gray, Ron, Wawer, Maria, Ndyanabo, Anthony, Kasule, Jingo, Serwadda, David, Castelnuovo, Barbara, Hoog, Anja van’t, Reynolds, Steven James
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BioMed Central 2017
الموضوعات:	Research Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5568262/ https://ncbi.nlm.nih.gov/pubmed/28830382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2680-6
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

مواد مشابهة